Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)

By J. Banales, V. Cardinale, G. Carpino, M. Marzioni, Jesper B. Andersen, P. Invernizzi, G. Lind, T. Folseraas, S. Forbes, L. Fouassier and 14 more. Nature Reviews Gastroenterology &Hepatology, 2016

1,270 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/853416d6fe2b0351d72cd649fa940d1129b8beaa

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. S. Affò
2. Apinya Jusakul
3. Ioana Cutcutache
4. Le-xing Yu
5. C. Yong
6. J. Lim
7. Mi Huang
8. Nisha T. Padmanabhan

Citations in the corpus

• Human Primary Liver Cancer -derived Organoid Cultures for disease modelling and drug screening (2017, neutral): “Thus, EpCAM, was highly expressed in all CCs (CC-1-3) and CHCs (CHC-1-2) tumouroids and corresponding patients’ tissues, but absent on HCCs tumouroids and tissues (Fig.”
• The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer (2016, background): “There is a strong geographical variation in CCA incidence, reflecting the presence of specific risk factors in some regions (168).”
• Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma (2017, background): “Cholangiocarcinoma (CCA) is the second most common hepatobiliary malignancy, accounting for 10% to 20% of primary liver cancers (1).”